Description de l'entreprise
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses.
Conseil d'administration & Conseil de surveillance
| PDG |
| Charles Kummeth |
| Conseil d'administration |
| Jim Hippel, Kim Kelderman, Will Geist, Shane Bohnen, Peter Breloer, Qi Cheng, Steve Crouse, Brenda S. Everson, Bob Gavin, Lynne Hohlfeld, Evett Kruka, Steven Silverman, Kevin Smyth, Peter Schuessler |
| Conseil de surveillance |
| Robert V. Baumgartner, Charles Kummeth, Dr. Alpna Seth, Dr. Joseph D. Keegan, Dr. Randolph C. Steer, Dr. Roland Nusse, Dr. Rupert Vessey, John L. Higgins, Julie L. Bushman |
Données de l'entreprise
| Nom: |
Bio-Techne Corp. |
| Adresse: |
614 McKinley Place N.E.,Minneapolis, MN 55413, USA |
| Téléphone: |
+1-612-379-2956 |
| Fax: |
+1-612-656-4400 |
| Courriel: |
info@bio-techne.com
|
| Internet: |
bio-techne.com/ |
| Industrie: |
Healthcare |
| Secteur: |
Medical Products |
| Sous-secteur: |
Advanced Medical Devices |
| Fin de l'exercice financier: |
30/06 |
| Flotte libre: |
79.40% |
| IPO date: |
08/05/1989 |
Relations avec les investisseurs
| Nom: |
David Clair |
| Téléphone IR: |
+1-612-656-4416 |
| IR-Fax: |
- |
| E-mail IR: |
ir@bio-techne.com
|
